1.Aging parameters of the accelerated aging procedure through D-Galactose induction
Ronald Winardi Kartika ; Kris Herawan Timotius ; Veronika Maria Sidharta ; Tena Djuartina ; Cynthia Retna Sartika
Acta Medica Philippina 2024;58(23):104-109
Background and Objectives:
Intraperitoneal injection (i.p.) of D-galactose (D-gal) accelerates aging and develops aging models. A low dose of long-term use and a high dose of short-term use of D-gal can induce natural aging in mice, like brain, cardiac, liver, renal, and skin aging, and erectile dysfunction. Our research aims to determine whether a high dose of short-term use of D-gal. i.p. in rats can induce natural aging and affect the following parameters: body weight (BW), Superoxide Dismutase (SOD), Vascular endothelial growth factor (VEGF), C-reactive protein (CRP), and myostatin.
Methods:
A daily D-gal i.p. dose of 300 mg/ml/kg for seven days was carried out to induce aging parameters in the rats. After seven days, the body and gastrocnemius circumference of the rats were weighed, and biochemical analysis for SOD, VEGF, CRP, and myostatin in the blood plasma was done.
Results:
The data obtained were analyzed using nonparametric statistics Friedman test and Mann-Whitney test. After the seven day-intervention, both the control (NaCl 0.9% i.p.) and the high dose of short-term use of D-gal i.p. groups showed no significant difference in the body weight and gastrocnemius circumference. However, D-gal administration could increase the blood plasma level of SOD, VEGF, CRP, and myostatin.
Conclusion
We conclude that a high dose of short-term intraperitoneal D-galactose can be administrated to induce aging in rat models. The SOD, VEGF, CRP and myostatin can be used as aging parameters.
Aging
;
D-Galactose
;
Galactose
;
Myostatin
;
VEGF
;
Vascular Endothelial Growth Factor A
2.Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer.
Han Jo KIM ; Moo Jun BAEK ; Dong Hyun KANG ; Sang Cheol LEE ; Sang Byung BAE ; Kyu Taek LEE ; Namsu LEE ; Hyungjoo KIM ; Dongjun JEONG ; Tae Sung AHN ; Moon Soo LEE ; Dae Sik HONG ; Jong Ho WON
Annals of Coloproctology 2018;34(2):88-93
PURPOSE: Animal models show a strong relationship between lymphangiogenesis and lymph node metastasis. However, the clinical significance of lymphangiogenesis in patients with colorectal cancer (CRC) remains uncertain. This study aimed to evaluate the association between c-Met and lymphangiogenic factors and to elucidate the prognostic significance of c-Met in patients with CRC. METHODS: A total of 379 tissue samples were obtained from surgically resected specimens from patients with CRC at Soonchunhyang University Cheonan Hospital between January 2002 and December 2010. The expressions of c-Met, vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGF receptor (VEGFR)-3, and podoplanin were examined using immunohistochemistry. The expression of c-Met and clinical factors were analyzed. RESULTS: Of the 379 tissues, 301 (79.4%) had c-Met expression. High expression of c-Met in tumor cells was significantly associated with high expression of VEGF-C (P < 0.001) and VEGFR-3 (P = 0.001). However, no statistically significant association with podoplanin (P = 0.587) or VEGF-D (P = 0.096) was found. Of the 103 evaluable patients, expression of c-Met in tumor cells was significantly associated with advanced clinical stage (P = 0.020), positive lymph node status (P = 0.038), and high expression of VEGF-C (P = 0.020). However, no statistically significant association with podoplanin (P = 0.518), VEGFR-3 (P = 0.085), VEGF-D (P = 0.203), or overall survival (P = 0.360) was found. CONCLUSION: Our results provide indirect evidence for an association and possible regulatory link of c-Met with the lymphangiogenic markers, but c-Met expression in patients with CRC is not a prognostic indicator for overall survival.
Chungcheongnam-do
;
Colorectal Neoplasms*
;
Humans
;
Immunohistochemistry
;
Lymph Nodes
;
Lymphangiogenesis
;
Models, Animal
;
Neoplasm Metastasis
;
Receptors, Vascular Endothelial Growth Factor
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factor Receptor-3
3.STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.
Yujuan CHEN ; Jing WANG ; Xiaodong WANG ; Xuejuan LIU ; Hongjiang LI ; Qing LV ; Jingqiang ZHU ; Bing WEI ; Ying TANG
Journal of Breast Cancer 2013;16(1):40-49
PURPOSE: The aim of this study is to explore signal transducer and activator of transcription 3 (STAT3) expression in breast cancer and to analyze the detailed mechanism that STAT3 contributes to the progression of breast cancer. METHODS: We retrospectively analyzed the clinicopathologic characteristics and overall survival (OS) of 140 breast cancer patients after curative surgery, and detected STAT3 expression, phosphorylated STAT3 (pSTAT3) expression, Ki-67 expression, vascular endothelial growth factor (VEGF)-C and -D expression in breast cancer tissues, and adjacent nontumor tissues. Survival analysis and relationship analysis were adopted for demonstrated the important mechanism of STAT3 contribution to progression of breast cancer. RESULTS: STAT3 expression, pSTAT3 expression, Ki-67 expression, VEGF-C expression, and VEGF-D expression in breast cancer tissues were significantly higher than those in adjacent nontumor tissues, respectively. With survival analysis, only number of lymph node metastasis (N stage) was identified as the independent predictors of the OS of breast cancer patients. Besides, we demonstrated there was the most prominent correlation between STAT3 expression and lymph node metastasis in breast cancer tissues by using the multinominal regression method. CONCLUSION: STAT3, a poor survival biomarker potential association with lymph node metastasis, was suitable for predication the OS of breast cancer patients after curative resection.
Breast
;
Breast Neoplasms
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prognosis
;
Retrospective Studies
;
STAT3 Transcription Factor
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
4.Comparative Analysis of Vascular Endothelial Growth Factor-A, C, D Expression in Colorectal Cancer with Liver Metastasis.
Kwang Sik CHUN ; Kyung Ha LEE ; In Sang SONG ; Ji Yeon KIM ; Je Ryong KIM ; Moon Sang AHN ; Sang Il LEE ; Jong Hyun PARK ; Song E CHOI ; Dae Young KANG ; Kyu Sang SONG
Journal of the Korean Surgical Society 2009;76(5):307-315
PURPOSE: We aimed to investigate the correlations between expressions of angiogenic cytokines VEGF-A, C, D of primary colorectal cancer and liver metastasis. METHODS: We examined paraffin-embedded primary colorectal cancer tissue from 45 patients who had liver resection due to colorectal liver metastasis (metastasis group) and 37 patients who had surgical resection due to colorectal cancer only (control group). In the control group, local recurrence and distant metastasis had not occurred. Immunohistochemical staining for VEGF-A, C and D was performed. We analysed the correlations between expression of VEGF-A, C and D in primary colorectal cancer tissues and clinicopathologic parameters. RESULTS: VEGF-A expressions of primary colorectal carcinoma were not different between the two groups. VEGF-C was more frequently expressed in the metastasis group (P=0.008) but VEGF-D was more expressed in the control group (P=0.003). Patients with VEGF-C negative and VEGF-D positive expression were predominant in the control group (P=0.020). Tumor location, T stage, lymph node metastasis and tumor differentiation were not related with the expressions of VEGF-A, C, D but only preoperative CEA was positively correlated with VEGF-A and C expression. CONCLUSION: Expressions of VEGF-C in primary tumor were more frequent in metastatic colorectal cancer and expressions of VEGF-D were more frequent in nonmetastatic colorectal cancer. More large-scale prospective studies for VEGF-C and D expression in colorectal cancer are necessary.
Colorectal Neoplasms
;
Cytokines
;
Humans
;
Liver
;
Lymph Nodes
;
Neoplasm Metastasis
;
Recurrence
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
5.Prediction of Invasiveness by the Expressions of CD105 (Endoglin), D2-40 and Vascular Endothelial Growth Factors A and D in the Endoscopic Biopsy Tissue of Stomach Cancer Patients.
Sungsoo KIM ; Tae Jin LEE ; Beom Kyu KIM ; Sung Jae CHA ; Sung Jun PARK ; In Taek CHANG ; Sung Il PARK
Journal of the Korean Surgical Society 2007;72(5):358-368
PURPOSE: CD105 (endoglin) has been shown to be a more useful marker to identify the proliferating endothelium involved in tumor angiogenesis than are the panendothelial markers. The monoclonal antibody D2-40 is a specific lymphatic endothelial marker. METHODS: We investigated CD105, lymphatic vessel marker (D2-40), vascular endothelial growth factor (VEGD)-A and the VEGF-D expressions as possible prognostic markers in the endoscopic biopsy tissue of stomach cancer patients. The pre-operative endoscopic biopsies and surgical biopsies from 73 patients were immunostained for CD105, D2-40, VEGF-A and VEGF-D. Positively stained microvessels were counted in densely vascular foci (hot spots) at a x200 field in each specimen. RESULTS: The microvessel density (MVD) and lymphatic vessel density (LVD), according to the CD105 and D2-40 expressions of the endoscopic biopsies, showed a statistically significant correlation with the surgical biopsies. The MVD via CD105 a showed statistically significant correlation with the histologic differentiation, T-stage, nodal metastasis and stage in the endoscopic biopsies and surgical biopsies, respectively. The lympathic vessel density (LVD) via D2-40 showed a statistically significant correlation with T-stage, nodal metastasis and stage in the endoscopic biopsies. The expressions of VEGF-A and VEGF-D showed a statistically significant correlation with the MVD and LVD. CONCLUSION: The MVD, as determined by the CD105 expression and the LVD as determined by the D2-40 expression may be useful markers for predicting the invasiveness with using a pre-operative endoscopic biopsy of stomach cancer.
Biopsy*
;
Endothelium
;
Humans
;
Lymphatic Vessels
;
Microvessels
;
Neoplasm Metastasis
;
Stomach Neoplasms*
;
Stomach*
;
Vascular Endothelial Growth Factor A*
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factors*
6.Metastasis via Peritumoral Lymphatic Dilation in Oral Squamous Cell Carcinoma.
Han Seok KIM ; Young Wook PARK
Maxillofacial Plastic and Reconstructive Surgery 2014;36(3):85-93
PURPOSE: Nodal metastasis is the main prognostic factor in the patients with oral squamous cell carcinoma (OSCC). We investigated the association between tumor-associated lymphatics and OSCC characteristics. METHODS: Thirty-four specimens were used for the immunohistochemical staining with the antibody for vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGF receptor (VEGFR)-3, phosphorylated VEGFR-3, D2-40, and matrix metallproteinases (MMPs). We observed the distribution of the lymphangiogenic factors and quantified the degree of expression. We determined lymphatic vessel density (LVD) and lymphatic vessel dilatation with D2-40 immunostaining. We assessed the association of LVD or lymphatic vessel dilatation with tumor progression or tumor differentiation. RESULTS: OSCC cells expressed lymphangiogenic ligands. Lymphangiogenic receptor, VEGFR-3, was expressed and activated in some tumor cells as well as in tumor-associated endothelial cells. LVD was not associated with tumor size or nodal status, but lymphatic vessel dilatation was higher in tumors with nodal metastasis, and also higher in poorly differentiated tumors. In stromal area of OSCC, MMP-1 and MMP-10 were up-regulated and the basement membrane of tumor-associated endothelial cells was destroyed by these collagenases. CONCLUSION: In the primary tumors with nodal metastasis, especially in poorly differentiated OSCC, tumor cells invaded the dilated lymphatic vessels via ruptured sites. MMP-1 and MMP-10 are important in the lysis of the glycocalyx inside the tumor-associated lymphatic endothelial cells.
Basement Membrane
;
Carcinoma, Squamous Cell*
;
Collagenases
;
Dilatation
;
Endothelial Cells
;
Glycocalyx
;
Humans
;
Ligands
;
Lymphatic Vessels
;
Neoplasm Metastasis*
;
Receptors, Vascular Endothelial Growth Factor
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factor Receptor-3
7.Expression of Vascular Endothelial Growth Factors A,C and D in Gastric Adenocarcinoma.
Myoung Ja CHUNG ; Jin Wook LEE ; Ki Hoon YU ; Doo Hyun YANG ; Kyu Yun JANG ; Woo Sung MOON ; Myoung Jae KANG ; Dong Geun LEE
Korean Journal of Pathology 2005;39(2):99-105
BACKGROUND: Vascular endothelial growth factor (VEGF)-C and VEGF-D are novel growth factors that regulate lymphatic vessel growth. This study was designed to examine whether the expression of three VEGF family members, VEGF-A, VEGF-C and VEGF-D are associated with the clinicopathologic parameters, especially with lymph node metastasis, in advanced gastric carcinomas. METHODS: Immunohistochemical staining was performed for VEGF-A, VEGF-C, and VEGF-D in the surgically resected specimens from 102 patients with advanced gastric carcinoma. The mRNA expressions of the three VEGF family members were assessed in 16 cases of tumor tissues and their corresponding non-neoplastic tissues. RESULTS: Of the 102 gastric carcinomas, 74 (73%), 82 (80%), and 34 (33%) cases showed cytoplasmic immunoreactivity for VEGF-A, VEGF-C and VEGF-D, respectively. Both VEGF-A and VEGF-C expressions were associated with lymphatic invasion and lymph node metastasis (p<0.05), but the VEGF-D expression was not associated with them (p>0.05). In the tumor tissue, VEGF-C mRNA expression was greater, while VEGF-D mRNA expression was lower than in the nonneoplatic tissue adjacent to the tumor. CONCLUSIONS: VEGF-A and VEGF-C may play important roles for the lymphatic spread of gastric carcinoma. We suggest that neutralizing both VEGF-A and VEGF-C may be reguired to block lymph node metastasis.
Adenocarcinoma*
;
Cytoplasm
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
Lymph Nodes
;
Lymphatic Vessels
;
Neoplasm Metastasis
;
RNA, Messenger
;
Vascular Endothelial Growth Factor A*
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factors*
8.Microvessel Density and Vascular Endothelial Growth Factor Expression in Invasive Breast Carcinomas.
Mi Yeong JEON ; Mee Young SOL ; Kyung Sun PARK ; Hye Kyoung YOON
Korean Journal of Pathology 2000;34(2):138-144
Angiogenesis is essential for tumor growth and metastasis, however, the prognostic value of neovascularization is undetermined. The aim of this study is to evaluate the prognostic significance of microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression in breast carcinomas. An immunohistochemical stains for CD 31 (DAKO) to estimate MVD and VEGF (Santa Cruz) were done on 40 cases of invasive breast carcinoma. MVD was calculated as an average count of vessels per 200 power field in the most vascularized areas. VEGF expression was interpreted according to staining intensity and number of positive cells. Mean MVD was 35, and MVD was not correlated with lymph node metastasis or histologic grade, but high MVD (mean MVD>35) showed an increasing tendency in cases with larger size, negative ER/PR, and positive cathepsin D. All of the cases showed VEGF expression, but VEGF expression was not correlated with tumor size, histologic grade, lymph node metastasis, ER/PR status, and cathepsin D expression. These results suggest that MVD and VEGF expressions are not reliable prognostic factors.
Breast Neoplasms*
;
Breast*
;
Cathepsin D
;
Coloring Agents
;
Lymph Nodes
;
Microvessels*
;
Neoplasm Metastasis
;
Vascular Endothelial Growth Factor A*
9.Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer.
Yoon Ho KO ; Chan Kwon JUNG ; Myung Ah LEE ; Jae Ho BYUN ; Jin Hyoung KANG ; Kyo Young LEE ; Keon Hyun JO ; Young Pil WANG ; Young Seon HONG
Cancer Research and Treatment 2008;40(3):133-140
PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis via the VEGF receptor 3 (VEGFR-3). We sought to determine whether VEGF-C, VEGF-D and VEGFR-3 are involved in the clinical outcomes of patients with resected NSCLC. MATERIALS AND METHODS: Using immunohistochemical staining, we investigated the protein expressions of VEGF-C, VEGF-D and VEGFR-3 in the tissue array specimens from patients who underwent resection for NSCLC. The immunoreactivity for p53 was also examined. The clinicopathological implications of these molecules were statistically analyzed. RESULTS: Analysis of a total of 118 specimens showed that VEGF-C, VEGF-D and their co-expression were significantly associated with more advanced regional lymph node metastasis (p=0.019, p=0.044 and p=0.026, respectively, N2 versus N0 and N1). A VEGFR-3 expression had a strong correlation with peritumoral lymphatic invasion (p=0.047). On the multivariate analysis for survival and recurrence, pathologic N2 lymph node metastasis was the only independent prognostic factor, but none of the investigated molecules showed any statistical correlation with recurrence and survival. CONCLUSIONS: The present study revealed that high expressions of VEGF-C and VEGF-D were strongly associated with more advanced regional lymph node metastasis in patients with resected NSCLC.
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung
;
Lymph Nodes
;
Lymphangiogenesis
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Receptors, Vascular Endothelial Growth Factor
;
Recurrence
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factor Receptor-3
;
Vascular Endothelial Growth Factors
10.The Correlation between the Expression of E-cadherin, VEGF-C, VEGF-D and the Real Extent of Lymph Node Metastases using Cytokeratin 18 in Early Gastric Cancer.
Dae Hoon KIM ; Hyo Yung YUN ; Young Jin SONG ; Dong Hee RYU ; In Choel MIN ; Rohyun SUNG ; Sang Eok LEE
Journal of the Korean Gastric Cancer Association 2008;8(2):70-78
PURPOSE: VEGF-C and VEGF-D are angiogenetic factors, and abnormal expression of E-cadherin hasa role in the progression of gastric carcinoma. The aim of this study was to evaluate the relationship between the expression of E-cadherin, VEGF-C and VEGF-D with the presence of lymph node metastases (LNM) using cytokeratin 18 in early gastric cancer (EGC). MATERIALS AND METHODS: Immunohistochemical staining for E-cadherin, VEGF-C and VEGF-D was performed in 49 EGC patients from March 1997 to December 2002. To evaluate the real extent of LNM, 1,562 lymph nodes from 49 patients were re-examined with the use of cytokeratin 18. RESULTS: Eleven (0.7%) LNM were newly found in 12.2% (n=6) of patients. The real LNM rate was 3.6% in mucosal invasive (m) cancer and 38.1% in submucosal invasive (sm). Stage migration was seen in three patients (6.1%). Abnormal expression of E-cadherin was detected in 36.7% of the patients and expression of VEGF-C and VEGF-D was detected in 16.3% and 36.7% of the patients, respectively. Abnormal expression of E-cadherin was significantly correlated with tumor differentiation (P=0.0103) and Lauren classification (P<0.0001). There was no positive relationship of VEGF-C and VEGF-D expression with the clinicopathological findings for EGC including LNM. However, the frequency of lymph node metastases was significantly higher in patients that demonstrated abnormal expression of E-cadherin with positive immunoreactivity of VEGF-C or VEGF-D (P=0.031). CONCLUSION: In present study, we could not demonstrate a relationship between the presence of LNM and expression of VEGF-C and VEGF-D in EGC. However, VEGF-C or VEGF-D expression, in addition to the abnormal expression of E-cadherin, was correlated with the real extent of LNM in EGC.
Cadherins
;
Humans
;
Keratin-18
;
Keratins
;
Lymph Nodes
;
Neoplasm Metastasis
;
Stomach Neoplasms
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D